Your browser doesn't support javascript.
loading
Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.
Thiem, Kathrin; Hoeke, Geerte; Zhou, Enchen; Hijmans, Anneke; Houben, Tom; Boels, Margien G; Mol, Isabel M; Lutgens, Esther; Shiri-Sverdlov, Ronit; Bussink, Johan; Kanneganti, Thirumala D; Boon, Mariëtte R; Stienstra, Rinke; Tack, Cees J; Rensen, Patrick Cn; Netea, Mihai G; Berbée, Jimmy Fp; van Diepen, Janna A.
Afiliação
  • Thiem K; Department of Internal Medicine and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hoeke G; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Zhou E; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Hijmans A; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Houben T; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Boels MG; Department of Internal Medicine and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mol IM; Departments of Molecular Genetics, Human Biology and Surgery, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
  • Lutgens E; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Shiri-Sverdlov R; Division of Nephrology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Bussink J; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Kanneganti TD; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Boon MR; Division of Experimental Vascular Biology, Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Stienstra R; Institute for Cardiovascular Prevention, Ludwig Maximilians University of Munich, Munich, Germany.
  • Tack CJ; Departments of Molecular Genetics, Human Biology and Surgery, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
  • Rensen PC; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Netea MG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Berbée JF; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • van Diepen JA; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Diab Vasc Dis Res ; 17(1): 1479164119892140, 2020.
Article em En | MEDLINE | ID: mdl-31868000
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Aorta / Glicemia / Células-Tronco Hematopoéticas / Deleção de Genes / Lectinas Tipo C / Diabetes Mellitus Experimental / Aterosclerose / Proteínas Adaptadoras de Sinalização CARD Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Aorta / Glicemia / Células-Tronco Hematopoéticas / Deleção de Genes / Lectinas Tipo C / Diabetes Mellitus Experimental / Aterosclerose / Proteínas Adaptadoras de Sinalização CARD Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article